Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SI-BONE, Inc. Director's Dealing 2020

Jun 19, 2020

32647_dirs_2020-06-19_681fcf5c-e17a-42a1-89cb-0ff811e95e83.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SI-BONE, Inc. (SIBN)
CIK: 0001459839
Period of Report: 2020-06-18

Reporting Person: FRANCIS LAURA (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-06-18 Common Stock M 2418.00 $4.68 Acquired 141639.00 Direct
2020-06-18 Common Stock M 5158.00 $4.32 Acquired 146797.00 Direct
2020-06-18 Common Stock S 5158.00 $17.0673 Disposed 141639.00 Direct
2020-06-18 Common Stock S 2418.00 $17.0673 Disposed 139221.00 Direct
2020-06-19 Common Stock M 2395.00 $4.32 Acquired 141616.00 Direct
2020-06-19 Common Stock S 2395.00 $17.3008 Disposed 139221.00 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-06-18 Stock Option (Right to Buy) $4.68 M 2418.00 Disposed 2027-03-01 Common Stock (2418.00) Direct
2020-06-18 Stock Option (Right to Buy) $4.32 M 5158.00 Disposed 2025-05-25 Common Stock (5158.00) Direct
2020-06-19 Stock Option (Right to Buy) $4.32 M 2395.00 Disposed 2025-05-25 Common Stock (2395.00) Direct

Footnotes

F1: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F2: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $17.00 to $17.28, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes.

F3: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $17.06 to $17.41, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes.

F4: Includes 86,134 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F5: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date.